HSBC Holdings
CRBP icon

HSBC Holdings’s Corbus Pharmaceuticals CRBP Stock Holding History

HSBC Holdings’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Buy
+55,224
New +$523K ﹤0.01% 2278
2019
Q4 		– Sell
-1,357
Closed -$198K – 3062
2019
Q3 		$198K Buy
+1,357
New +$236K ﹤0.01% 2871
2017
Q2 		– Sell
-1,162
Closed -$288K – 2195
2017
Q1 		$288K Buy
+1,162
New +$285K ﹤0.01% 1821

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

HSBC Holdings's CRBP Position: Q2 2026 in Review

HSBC Holdings opened a new position in Corbus Pharmaceuticals (CRBP) in Q2 2026: 55,224 shares worth $505K. The stake represents ﹤0.01% of the portfolio and ranks #2278 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in CRBP as recently as Q3 2019.

HSBC Holdings first reported a position in CRBP in Q1 2017 and has held it in 3 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • HSBC Holdings held 55,224 shares of Corbus Pharmaceuticals worth $505K as of Q2 2026.
  • Corbus Pharmaceuticals was a new HSBC Holdings position in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2278 holding.
  • HSBC Holdings first reported a position in Corbus Pharmaceuticals in Q1 2017 and has held it in 3 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.